Home / Knowledge Centre /

The five fundamentals of selecting a clinical supply partner for your early phase trial

Today, a product’s journey can be perilous. Early phase trials, involving relatively small groups of patients and designed primarily to determine safe dose ranges and potential side effects, represent
a crucial leg of this journey. If approached correctly, sponsors can obtain vital information that provides a springboard for progression into successful phase II and III trials and eventual market approval.

From entrepreneurial biotechs to big pharma, selecting the best fit CDMO partner to manage packaging and distribution of clinical supply for early phase trials is fundamental to bigger-picture success.

Download our Guide below to find out more.

View Resource
Almac Logo

Almac Clinical Services

Guided by our extensive clinical supply experience and expertise, Almac Clinical Services  is  recognised as an innovative,  global solution provider within the specialised and complex market of clinical trial supply.

Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.

Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies